• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

adjuvant vaccines

handshake deal shake hand arrows ok yes
Favicon Fierce Pharma

Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals

Several other pharma companies have signed material transfer agreements so that they can experiment with Novavax's Matrix-M before committing to a deal.
Angus Liu Apr 6, 2026 8:37am
unlabeled vaccine

'Active' vaccine adjuvant boosts COVID, flu antibodies in mice

Jul 9, 2024 4:00am
Novavax

Novavax's 2nd round of job cuts impacted 12% of staff

Jan 31, 2024 11:57am
The spike protein on the SARS-CoV-2 virus up close

Adjuvants supercharge existing COVID-19 vaccines in mice

Sep 8, 2023 12:15pm
GSK

GSK’s phase 3 RSV vaccine data suggest it has an edge on Pfizer

Oct 13, 2022 7:00am
Concept of SARS-CoV-2 or COVID-19

Sanofi, GSK post next-gen COVID-19 data to unlock booster market

Jun 13, 2022 8:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings